Humoral Immunity Due to Long-Lived Plasma Cells

Slides:



Advertisements
Similar presentations
Volume 42, Issue 2, Pages (February 2015)
Advertisements

Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 5, Issue 1, Pages (January 2009)
The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles  Kathryn A. Pape, Drew M. Catron,
Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Following the Development of a CD4 T Cell Response In Vivo
Feedback Regulation of Pathogen-Specific T Cell Priming
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Volume 8, Issue 2, Pages (February 1998)
Volume 30, Issue 4, Pages (April 2009)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
by Éric Aubin, Réal Lemieux, and Renée Bazin
Silvia Bolland, Jeffrey V Ravetch  Immunity 
TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow by Shoichiro Tsuji, Catarina Cortesão,
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 42, Issue 2, Pages (February 2015)
Preventing Allograft Rejection by Targeting Immune Metabolism
Volume 30, Issue 3, Pages (March 2009)
Viral Infection Results in Massive CD8+ T Cell Expansion and Mortality in Vaccinated Perforin-Deficient Mice  Vladimir P Badovinac, Sara E Hamilton, John.
Volume 18, Issue 5, Pages (May 2003)
Volume 28, Issue 2, Pages (February 2008)
Ananda W Goldrath, Michael J Bevan  Immunity 
Volume 21, Issue 1, Pages (July 2004)
Volume 6, Issue 4, Pages (April 1997)
Volume 11, Issue 6, Pages (June 2012)
Volume 31, Issue 1, Pages (July 2009)
Volume 25, Issue 3, Pages (September 2006)
Volume 6, Issue 5, Pages (May 1997)
Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells 
Volume 92, Issue 4, Pages (February 1998)
Impaired Th2 Subset Development in the Absence of CD4
Volume 21, Issue 3, Pages (September 2004)
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Volume 19, Issue 4, Pages (October 2003)
Volume 19, Issue 2, Pages (February 2016)
Volume 29, Issue 2, Pages (August 2008)
Novel Role of the Ras Cascade in Memory B Cell Response
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
Role of B cells in TH cell responses in a mouse model of asthma
Volume 29, Issue 6, Pages (December 2008)
Volume 11, Issue 2, Pages (August 1999)
Volume 23, Issue 4, Pages (October 2005)
Volume 27, Issue 3, Pages (September 2007)
Volume 13, Issue 2, Pages (February 2006)
Natural IgE Production in the Absence of MHC Class II Cognate Help
Volume 13, Issue 6, Pages (November 2015)
Volume 5, Issue 1, Pages (January 2009)
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Dirk H Busch, Ingrid M Pilip, Sujata Vijh, Eric G Pamer  Immunity 
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation  Jian-Ming Li, Edmund K.
CD40, but Not CD40L, Is Required for the Optimal Priming of T Cells and Control of Aerosol M. tuberculosis Infection  Vanja Lazarevic, Amy J Myers, Charles.
Volume 32, Issue 1, Pages (January 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Eric A Butz, Michael J Bevan  Immunity 
Volume 41, Issue 1, Pages (July 2014)
Volume 29, Issue 4, Pages (October 2008)
Volume 38, Issue 3, Pages (March 2013)
Cell-Intrinsic IL-27 and gp130 Cytokine Receptor Signaling Regulates Virus-Specific CD4+ T Cell Responses and Viral Control during Chronic Infection 
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Volume 37, Issue 5, Pages (November 2012)
Matthew A. Williams, Eugene V. Ravkov, Michael J. Bevan  Immunity 
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 32, Issue 1, Pages (January 2010)
Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10  Ela Martin, Brendan.
David Voehringer, Kanade Shinkai, Richard M Locksley  Immunity 
Volume 7, Issue 3, Pages (September 1997)
Volume 30, Issue 5, Pages (May 2009)
Volume 9, Issue 3, Pages (March 2011)
B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
Presentation transcript:

Humoral Immunity Due to Long-Lived Plasma Cells Mark K Slifka, Rustom Antia, Jason K Whitmire, Rafi Ahmed  Immunity  Volume 8, Issue 3, Pages 363-372 (March 1998) DOI: 10.1016/S1074-7613(00)80541-5

Figure 1 Kinetics of the Humoral Response Following Acute LCMV Infection Adult BALB/c mice (6–8 weeks old) were infected intraperitoneally with 2 × 105 pfu of LCMV Armstrong and analyzed for the presence of virus-specific antibody in the serum (A) and the number of LCMV-specific ASC (B) or memory B cells (MBC) (C) in the spleen and bone marrow. Virus-specific IgG in the serum was determined by ELISA (Ahmed et al. 1984) and measured in ELISA units. LCMV-specific plasma cells were quantitated by ELISPOT assay (Slifka et al. 1995) and are defined as cells that lack detectable surface Ig and MHC class II molecules (Abney et al. 1978; Halper et al. 1978) and spontaneously secrete large amounts of specific antibody directly ex vivo without restimulation by antigen. Memory B cells were analyzed by limiting dilution analysis (Slifka and Ahmed 1996a) and are defined as surface Ig+MHC class II+ cells that do not spontaneously secrete antibody but proliferate and differentiate into antibody-secreting plasma cells following restimulation with antigen. The data shown represent the average of three to six mice at each timepoint. Immunity 1998 8, 363-372DOI: (10.1016/S1074-7613(00)80541-5)

Figure 3 Plasma Cell Survival after Memory B Cell Depletion (A) Plasma cells were quantitated in the spleen and bone marrow of irradiated/reconstituted LCMV-immune mice and compared to nonirradiated immune mice using an ELISPOT assay (Slifka et al. 1995). The data are presented as a ratio of the number of LCMV-specific ASC observed in irradiated mice divided by the average number of ASC observed in nonirradiated control mice (three or four control mice per time point). The ratio of virus-specific ASC in the spleen (open circles) and bone marrow (BM) (closed circles) of individual irradiated mice are shown at the indicated time points. The decay rate of plasma cell numbers was obtained from the slope of the log-linear plot shown and indicated a t1/2 of 94 days for plasma cells in the bone marrow and 172 days for plasma cells in the spleen. (B) The total number of virus-specific plasma cells in the spleen and bone marrow of irradiated/reconstituted LCMV-immune BALB/c mice were compared to nonirradiated controls at 240 days postirradiation. Each bar represents the number of virus-specific plasma cells in the spleen or bone marrow of individual mice. After reconstitution with naive IgHb B cells, no LCMV-specific IgHb-secreting plasma cells were detected by the ELISPOT assay. (C) After irradiation, LCMV immune mice (IgHa) were reconstituted with allotypic (IgHb) spleen and bone marrow cells. At 240 days postirradiation/reconstitution, flow cytometry showed that the host IgHa-bearing B cells were completely replaced by naive allotypic IgHb-bearing B cells. Each sample was double-stained for the B cell marker B220 (vertical axis) and the allotypic (donor) marker IgMb (horizontal axis). The contour plot represents 30,000 gated events. (D) Spleen and bone marrow cells from irradiated LCMV-immune mice (240 days postirradiation) were depleted of Ig+ or MHC class II+ cells by panning on antibody-coated plates. This procedure depleted more than 95% of mature B cells but did not decrease the number of ASC scored by the ELISPOT assay, indicating that these LCMV-specific ASC have the phenotype of plasma cells. Immunity 1998 8, 363-372DOI: (10.1016/S1074-7613(00)80541-5)

Figure 2 Virus-Specific Antibody Production after Memory B Cell Depletion At 60 days postinfection, LCMV-immune BALB/c IgHa mice were irradiated to deplete memory B cells and then reconstituted with naive BALB/c IgHb B cells. The levels of LCMV-specific IgG (A), IgG1 (B), and IgG2a (C) in the serum of these mice were determined by ELISA (Ahmed et al. 1984). LCMV-specific antibody consisted entirely of the host IgHa allotype; no donor IgHb (IgG2ab) antibody responses were detected. The half-life of plasma cells was obtained by fitting the data for antibody concentration A[t] in individual mice to a biexponential decay described by the function A(t) = [A(0)/(a − p)][a(1 − f)e−pt + (af − p)e−at]. The decay rate of free Ig was determined by passively transferring LCMV-immune serum into naive recipients and monitoring the decline in serum antibody levels by ELISA (open triangles, circles, and diamonds represent three individual recipient mice). The mean values (± 1 SEM) for the half-lives of transferred Ig were t1/2 (total IgG), 11.7 ± 0.5 days; t1/2 (IgG1), 14.4 ± 0.4 days; and t1/2 (IgG2a), 13 ± 1 days. Immunity 1998 8, 363-372DOI: (10.1016/S1074-7613(00)80541-5)

Figure 4 Persistence of LCMV-Specific Antibody Production by Long-Lived Plasma Cells At 80 days postinfection, LCMV-immune C57BL/6 Thy1a IgHa mice were given 800 rad of total-body irradiation followed by an intravenous injection of naive C57BL/6 (IgHb) B cells, T cells, and bone marrow. After irradiation, LCMV-specific memory B cells were undetectable by limiting dilution analysis (<1 memory B cell per 106 spleen cells), and no LCMV-specific donor (IgHb) antibody was detected in the serum (data not shown). LCMV-specific serum IgG titers were monitored longitudinally in individual mice (each symbol denotes a mouse) by ELISA for more than 500 days postirradiation, and the survival of virus-specific plasma cells was determined by the mathematical model described in Figure 2. Immunity 1998 8, 363-372DOI: (10.1016/S1074-7613(00)80541-5)

Figure 5 Adoptive Transfer of LCMV-Specific Plasma Cells Results in Prolonged Antibody Production Bone marrow from LCMV-immune mice (containing 1.5 × 104 LCMV-specific plasma cells) was adoptively transferred into naive BALB/c recipients, and virus-specific serum IgG levels were measured by ELISA. The bone marrow cells were treated with an antiproliferative agent, mitomycin C, prior to transfer. Plasma cell half-life estimates in individual mice were fit by the model A(t) = [k/(a − p)][e−pt − e−at]. The open circles show antibody levels in individual mice that received mitomycin C–treated cells; the filled circles show the lack of a detectable antibody response (<10 ELISA units) in mice that received sonicated bone marrow cells. This demonstrated that the antibody response observed after bone marrow transfer was due to the transfer of plasma cells and not due to passively transferred antibody or viral antigen. Immunity 1998 8, 363-372DOI: (10.1016/S1074-7613(00)80541-5)